These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 989742)

  • 1. Comparison of reflex effects of levodopa and bromocriptine in Parkinsonism.
    McLellan DL
    Br Med J; 1976 Jul; 2(6029):235-6. PubMed ID: 989742
    [No Abstract]   [Full Text] [Related]  

  • 2. Interaction between bromocriptine and levodopa. Biochemical basis for an improved treatment for parkinsonism.
    Hutt CS; Snider SR; Fahn S
    Neurology; 1977 Jun; 27(6):503-10. PubMed ID: 577299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross tolerance between two dopaminergic ergot derivatives--bromocriptine and lergotrile.
    Teychenne PF; Rosin AJ; Plotkin CN; Calne DB
    Br J Clin Pharmacol; 1980 Jan; 9(1):47-50. PubMed ID: 6101955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DA agonists -- ergot derivatives: bromocriptine: management of Parkinson's disease.
    Mov Disord; 2002; 17 Suppl 4():S53-67. PubMed ID: 12211141
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of levodopa, lergotrile, and bromocriptine on brain iron, manganese, and copper.
    Weiner WJ; Nausieda PA; Klawans HL
    Neurology; 1978 Jul; 28(7):734-7. PubMed ID: 566875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bromocriptine - an important advance.
    Drug Ther Bull; 1976 Apr; 14(9):33-4. PubMed ID: 1278002
    [No Abstract]   [Full Text] [Related]  

  • 7. Letter: Bromocriptine in parkinsonism.
    Debono AG; Donaldson I; Marsden CD; Parkes JD
    Lancet; 1975 Nov; 2(7942):987-8. PubMed ID: 53479
    [No Abstract]   [Full Text] [Related]  

  • 8. Bromocriptine in Parkinsonism: long-term treatment, dose response, and comparison with levodopa.
    Parkes JD; Debono AG; Marsden CD
    J Neurol Neurosurg Psychiatry; 1976 Nov; 39(11):1101-8. PubMed ID: 1036999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metaclopramide and prolactin secretion in man: effects of pretreatment with L-dopa and 2-bromo-alpha-ergocryptine (CB-154).
    Delitala G; Masala A; Alagna S; Devilla L
    IRCS J Med Sci; 1975 Jun; 3(6):274. PubMed ID: 1165172
    [No Abstract]   [Full Text] [Related]  

  • 10. Brain dopamine receptor stimulation and the relief of Parkinsonism: relationship between bromocriptine and levodopa.
    Rinne UK; Marttila R
    Ann Neurol; 1978 Sep; 4(3):263-7. PubMed ID: 718139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bromocriptine:dopamine-receptor agonist.
    Dipalma JR
    Am Fam Physician; 1976 Dec; 14(6):88-9. PubMed ID: 1036662
    [No Abstract]   [Full Text] [Related]  

  • 12. Letter: Platelet and coagulation studies in patients treated with bromocriptine.
    Conard J; Samama M; Bousser MG; Bories F
    Br Med J; 1976 Aug; 2(6034):529-30. PubMed ID: 953674
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of the effects of bromocriptine and levodopa in Parkinson's disease.
    Godwin-Austen RB; Smith NJ
    J Neurol Neurosurg Psychiatry; 1977 May; 40(5):479-82. PubMed ID: 330825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between lergotrile and bromocriptine in parkinsonism.
    Teychenne PF; Pfeiffer RF; Bern SM; McInturff D; Calne DB
    Ann Neurol; 1978 Apr; 3(4):319-24. PubMed ID: 666273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Letter: Efficacy of bromocriptine in 2 cases of levodopa-resistant parkinsonism].
    Kissel P; Andre JM; Jacquier A
    Nouv Presse Med; 1976 Jan; 5(4):210. PubMed ID: 1264671
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical experience with bromocriptine, a central dopaminergic stimulator].
    Ludin HP; Kunz F; Lörincz P; Ringwald E
    Nervenarzt; 1976 Nov; 47(11):651-5. PubMed ID: 794749
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of levodopa and bromocriptine on blood pressure and plasma catecholamines in parkinsonians.
    Durrieu G; Senard JM; Tran MA; Rascol A; Montastruc JL
    Clin Neuropharmacol; 1991 Feb; 14(1):84-90. PubMed ID: 2029695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bromocriptine and lisuride in Parkinson disease.
    Lieberman AN; Gopinathan G; Neophytides A; Leibowitz M; Walker R; Hiesiger E
    Ann Neurol; 1983 Jan; 13(1):44-7. PubMed ID: 6830164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of L-dopa and lergotrile mesylate on the interaction of fluphenazine decanoate and amphetamine-induced stereotypy and mortality.
    Lemberger L; Kellams JJ; Small JG; Rowe H
    Commun Psychopharmacol; 1977; 1(5):501-7. PubMed ID: 564259
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of Parkinson's disease with bromocriptine.
    Jotkowitz S
    N Engl J Med; 1977 Sep; 297(9):508-9. PubMed ID: 578000
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.